143 related articles for article (PubMed ID: 6660858)
21. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
[TBL] [Abstract][Full Text] [Related]
22. Cefuroxime: human pharmacokinetics.
Foord RD
Antimicrob Agents Chemother; 1976 May; 9(5):741-7. PubMed ID: 949172
[TBL] [Abstract][Full Text] [Related]
23. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
24. The absolute bioavailability of caffeine in man.
Blanchard J; Sawers SJ
Eur J Clin Pharmacol; 1983; 24(1):93-8. PubMed ID: 6832208
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and absolute bioavailability of diltiazem in humans.
Ochs HR; Knüchel M
Klin Wochenschr; 1984 Apr; 62(7):303-6. PubMed ID: 6727272
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers.
Wenzler E; Ellis-Grosse EJ; Rodvold KA
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630194
[TBL] [Abstract][Full Text] [Related]
27. Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration.
Fleuren HL; Thien TA; Verwey-van Wissen CP; van Rossum JM
Eur J Clin Pharmacol; 1979 Feb; 15(1):35-50. PubMed ID: 421727
[TBL] [Abstract][Full Text] [Related]
28. Bretylium pharmacokinetics and bioavailabilities in man with various doses and modes of administration.
Garrett ER; Green JR; Bialer M
Biopharm Drug Dispos; 1982; 3(2):129-64. PubMed ID: 7104462
[TBL] [Abstract][Full Text] [Related]
29. Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs.
Supko JG; Garcia-Carbonero R; Puchalski TA; Malspeis L
Cancer Chemother Pharmacol; 2001 Sep; 48(3):202-8. PubMed ID: 11592341
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans.
Koup JR; Dubach UC; Brandt R; Wyss R; Stoeckel K
Antimicrob Agents Chemother; 1988 Apr; 32(4):573-9. PubMed ID: 3377466
[TBL] [Abstract][Full Text] [Related]
31. Saturable small intestinal drug absorption in humans: modeling and interpretation of cefatrizine data.
Yu LX; Amidon GL
Eur J Pharm Biopharm; 1998 Mar; 45(2):199-203. PubMed ID: 9704917
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of metipranolol in normal man.
Abshagen U; Betzien G; Kaufmann B; Endele G
Eur J Clin Pharmacol; 1982; 21(4):293-301. PubMed ID: 6120080
[TBL] [Abstract][Full Text] [Related]
33. Disposition of 14C-cefatrizine in man.
Gaver RC; Deeb G
Drug Metab Dispos; 1980; 8(3):157-62. PubMed ID: 6104579
[No Abstract] [Full Text] [Related]
34. Single- and multiple-dose pharmacokinetics of pipemidic acid in normal human volunteers.
Klinge E; Männistö PT; Mäntylä R; Mattila J; Hänninen U
Antimicrob Agents Chemother; 1984 Jul; 26(1):69-73. PubMed ID: 6476816
[TBL] [Abstract][Full Text] [Related]
35. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
[TBL] [Abstract][Full Text] [Related]
36. Absorption kinetics and bioavailability of cephalexin in the dog after oral and intramuscular administration.
Carli S; Anfossi P; Villa R; Castellani G; Mengozzi G; Montesissa C
J Vet Pharmacol Ther; 1999 Oct; 22(5):308-13. PubMed ID: 10597534
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers.
Frydman AM; Le Roux Y; Lefebvre MA; Djebbar F; Fourtillan JB; Gaillot J
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():65-79. PubMed ID: 3458699
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic studies of CP-74,667, a new quinolone, in laboratory animals.
Girard D; Gootz TD; McGuirk PR
Antimicrob Agents Chemother; 1992 Aug; 36(8):1671-6. PubMed ID: 1329625
[TBL] [Abstract][Full Text] [Related]
39. Absolute bioavailability of cefprozil after oral administration in beagles.
Barbhaiya RH; Wang L; Shyu WC; Pittman KA
Antimicrob Agents Chemother; 1992 Mar; 36(3):687-9. PubMed ID: 1622187
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers.
Huang YC; Colaizzi JL; Bierman RH; Woestenborghs R; Heykants J
Antimicrob Agents Chemother; 1986 Aug; 30(2):206-10. PubMed ID: 3767339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
